Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

Clinical trial NCT06888817 · RECRUITING

Trial details

NCT number: NCT06888817
Sponsor: The Netherlands Cancer Institute
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Radiation Necrosis High Grade Glioma (III or IV)Brain Metastasases Radiation Toxicity Radiation Effect Radiation Injury Radiation Injuries

Start date: 2025-06-19
Primary completion: 2028-07-01
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.